Corcept Therapeutics, Inc. (CORT)
46.16
+2.20
(+5.00%)
USD |
NASDAQ |
Apr 17, 16:00
47.00
+0.84
(+1.82%)
After-Hours: 05:21
Corcept Therapeutics SG&A Expense (Quarterly) : 130.24M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.898B |
| Terns Pharmaceuticals, Inc. | 8.699M |
| Integer Holdings Corp. | 57.21M |
| ACADIA Pharmaceuticals, Inc. | 155.62M |
| Catalyst Pharmaceuticals, Inc. | 48.23M |